Arbor Biotechnologies on Tuesday announced a new $74 million fundraise that comes as many of its peers in genetic medicine struggle to secure venture investment. The Series C round led by Arch Venture ...
As the Russian Su-57 stealth fighter jet enters serial production, the debate over how it stacks up against the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback